New Transgenic Rat Models Offer Superior Representation Of Human Cancers
Until recently, there has been a void in animal models [...]
Until recently, there has been a void in animal models [...]
Chronic lymphocytic leukemia (CLL) is a relatively rare cancer, but [...]
Hera BioLabs, a Lexington based contract research organization (CRO), announced [...]
The quality of pre-clinical translational research often hinges on assay validation and in vitro and in vivo predictive modeling. Hera BioLabs is creating specifically engineered cell and animal models which offer robust and relevant assay platforms for efficacy and toxicity studies.